MSB 3.42% $1.21 mesoblast limited

MSB Trading - 2020, page-6872

  1. 11,495 Posts.
    lightbulb Created with Sketch. 2295
    OMG Gilead news is amazing!!! we don't have a chance, cause covid treatment is all we've got!!!! AHHHHHH run for the hills, lol.


    https://hotcopper.com.au/data/attachments/2126/2126369-a86a5a52772cb360d81a872152b96d95.jpg



    Anthony Fauci, the director of NIAID, part of the National Institutes of Health, said the data are a “very important proof of concept” and that there was reason for optimism. He cautioned the data were not a “knockout.”
    The preliminary data showed that the time to recovery was 11 days on remdesivir compared to 15 days for placebo, a 31% decrease. The mortality rate for remdesivir group was 8%, compared to 11.6% for the placebo group; that mortality difference was not statistically significant.


    In new headlines out today.

    "
    Shorters see hope in Gilead drug, but Meso climbs on US market"
    Last edited by kenjikool: 30/04/20
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.21
Change
0.040(3.42%)
Mkt cap ! $1.381B
Open High Low Value Volume
$1.17 $1.22 $1.17 $5.683M 4.776M

Buyers (Bids)

No. Vol. Price($)
1 20000 $1.21
 

Sellers (Offers)

Price($) Vol. No.
$1.21 19746 3
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.